Chugai Pharmaceutical Reports First Half Fiscal Year Results

Chugai Pharmaceutical reported its first half fiscal year results with an EPS of ¥140.82 and revenue reaching ¥663,300 million. The company's operating profit stood at ¥319,600 million amid various expenses including research & development costs.

By Manshi Mamtora, CFA, SA News Editor · Seeking Alpha · July 24, 2026, 09:06 UTC

Chugai Pharmaceutical Reports First Half Fiscal Year Results

Topics: earnings_report pharmaceuticals

Read the full article at Seeking Alpha

More World news

Metalla Royalty & Streaming Reports Q3 Revenue Growth and Increased Adjusted EBITDA Seeking Alpha · November 12, 2026, 15:26 UTC
Fed Governor Michael Barr Warns AI Market Concentration Could Drive Income Inequality Seeking Alpha · November 12, 2026, 15:27 UTC
Jefferies Upgrades Pattern Group (PTRN) Following Strong Brand Acquisition Performance Seeking Alpha · November 12, 2026, 15:27 UTC
Pomerantz Law Firm Investigates Six Flags Entertainment Corporation Following Fatal Roller Coaster Accident PR Newswire · November 12, 2026, 15:30 UTC
SpaceX Partners with Qualcomm to Launch Starlink Mobile Cellular Service Motley Fool · November 12, 2026, 15:21 UTC
Blast Resources Appoints Andy Yackulic as CEO to Lead Uranium Exploration PR Newswire · November 12, 2026, 15:26 UTC
FMC Corporation Shares Decline 13% in Thursday Trading Seeking Alpha · November 12, 2026, 15:22 UTC
U.S. Stock Indices Decline Following Nvidia CEO Jensen Huang's Resignation Seeking Alpha · November 12, 2026, 15:23 UTC
EY Report Outlines Three Fundamental Shifts Required for Future-Ready Health Systems by 2040 PR Newswire · November 12, 2026, 15:24 UTC
ProLift Garage Doors Expands Franchise Services and Support Initiatives PR Newswire · November 12, 2026, 15:24 UTC